Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tolvaptan PK/PD in SIADH
NCT02009878Phase 2Completed
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization
- Start
- Nov 2013
- Primary completion
- Jun 2015
- Modality
- Small Molecules
- Countries
- 7
01
Overview
A Phase 2 trial of tolvaptan in syndrome of inappropriate antidiuretic hormone secretion (SIADH), sponsored by Otsuka Pharmaceutical Development & Commercialization. Started Nov 2013; status: completed.
02
Drugs
tolvaptan
03
Conditions
syndrome of inappropriate antidiuretic hormone secretion (SIADH)
Beyond the preview
Go deeper on NCT02009878.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02009878.